AAAAAA
Results: 101-125/1748
Authors:
Frew, AJ
Citation: Aj. Frew, Omalizumab - A viewpoint, DRUGS, 61(2), 2001, pp. 261-261
Authors:
Demoly, P
Citation: P. Demoly, Omalizumab - A viewpoint, DRUGS, 61(2), 2001, pp. 261-261
Authors:
McClellan, K
Perry, CM
Citation: K. Mcclellan et Cm. Perry, Oseltamivir - A review of its use in influenza, DRUGS, 61(2), 2001, pp. 263-283
Authors:
Dunn, CJ
Goa, KL
Citation: Cj. Dunn et Kl. Goa, Zafirlukast - An update of its pharmacology and therapeutic efficacy in asthma, DRUGS, 61(2), 2001, pp. 285-315
Authors:
Robertson, RP
Citation: Rp. Robertson, Pancreatic islet cell transplantation - Likely impact on current therapeutics for type 1 diabetes mellitus, DRUGS, 61(14), 2001, pp. 2017-2020
Authors:
Bungard, TJ
McAlister, FA
Johnson, JA
Tsuyuki, RT
Citation: Tj. Bungard et al., Underutilisation of ACE inhibitors in patients with congestive heart failure, DRUGS, 61(14), 2001, pp. 2021-2033
Authors:
Saller, R
Meier, R
Brignoli, R
Citation: R. Saller et al., The use of silymarin in the treatment of liver diseases, DRUGS, 61(14), 2001, pp. 2035-2063
Authors:
Turnidge, J
Citation: J. Turnidge, Responsible prescribing for upper respiratory tract infections, DRUGS, 61(14), 2001, pp. 2065-2077
Authors:
Tan, KS
Citation: Ks. Tan, Premenstrual asthma - Epidemiology, pathogenesis and treatment, DRUGS, 61(14), 2001, pp. 2079-2086
Authors:
Wing, DA
Citation: Da. Wing, Pyelonephritis in pregnancy - Treatment options for optimal outcomes, DRUGS, 61(14), 2001, pp. 2087-2096
Authors:
Ibbotson, T
Goa, KL
Citation: T. Ibbotson et Kl. Goa, Darbepoetin alfa, DRUGS, 61(14), 2001, pp. 2097-2104
Authors:
Besarab, A
Citation: A. Besarab, Darbepoetin alfa - A viewpoint, DRUGS, 61(14), 2001, pp. 2105-2106
Authors:
Nissenson, AR
Citation: Ar. Nissenson, Darbepoetin alfa - A viewpoint, DRUGS, 61(14), 2001, pp. 2105-2105
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Darbepoetin alfa - A viewpoint, DRUGS, 61(14), 2001, pp. 2106-2106
Authors:
Keating, GM
Jarvis, B
Citation: Gm. Keating et B. Jarvis, Orlistat - In the prevention and treatment of type 2 diabetes mellitus, DRUGS, 61(14), 2001, pp. 2107-2119
Authors:
Hollander, PA
Citation: Pa. Hollander, Orlistat - A viewpoint, DRUGS, 61(14), 2001, pp. 2120-2120
Authors:
Hauner, H
Citation: H. Hauner, Orlistat - A viewpoint, DRUGS, 61(14), 2001, pp. 2121-2121
Authors:
Curran, MP
Perry, CM
Citation: Mp. Curran et Cm. Perry, Amisulpride - A review of its use in the management of schizophrenia, DRUGS, 61(14), 2001, pp. 2123-2150
Authors:
Cordonnier, DJ
Zaoui, P
Halimi, S
Citation: Dj. Cordonnier et al., Role of ACE inhibitors in patients with diabetes mellitus, DRUGS, 61(13), 2001, pp. 1883-1892
Authors:
Buhrer, C
Hoehn, T
Hentschel, J
Citation: C. Buhrer et al., Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum, DRUGS, 61(13), 2001, pp. 1893-1899
Authors:
Keller, F
Griesshammer, M
Haussler, U
Paulus, W
Schwarz, A
Citation: F. Keller et al., Pregnancy and renal failure - The case for application of dosage guidelines, DRUGS, 61(13), 2001, pp. 1901-1920
Authors:
Velickovic, M
Benabou, R
Brin, MF
Citation: M. Velickovic et al., Cervical dystonia - Pathophysiology and treatment options, DRUGS, 61(13), 2001, pp. 1921-1943
Authors:
Klings, ES
Farber, HW
Citation: Es. Klings et Hw. Farber, Current management of primary pulmonary hypertension, DRUGS, 61(13), 2001, pp. 1945-1956
Authors:
Dunn, CJ
Wagstaff, AJ
Perry, CM
Plosker, GL
Goa, KL
Citation: Cj. Dunn et al., Cyclosporin - An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral((R)))(1) in organ transplantation, DRUGS, 61(13), 2001, pp. 1957-2016
Authors:
Goodin, DS
Citation: Ds. Goodin, Interferon-beta therapy in multiple sclerosis - Evidence for a clinically relevant dose response, DRUGS, 61(12), 2001, pp. 1693-1703